Approved But Unaffordable: The Hidden Denial That the Appeal Process Can't Fix

Your prior authorization went through. Your insurance company said yes. But when you get to the pharmacy, your copay is $1,800. You cannot afford it, so you do not fill the prescription.

This is what patient advocates call the "hidden denial" – coverage that exists on paper but is financially inaccessible in practice. It is one of the most common barriers to accessing specialty medications, and it is also one of the most poorly understood, because the standard appeal process is not designed to address it.

Understanding why this happens, what options exist, and how to access financial assistance can mean the difference between getting your medication and going without it.

Why Coverage Does Not Always Mean Access

Health insurance operates on a cost-sharing model. You pay premiums, deductibles, copays, and coinsurance. The insurance company pays the rest. For routine medications, this system works reasonably well because the cost-sharing amounts are manageable for most people.

For specialty medications, the system breaks down. A drug with a list price of $10,000 per month, placed on a plan's "specialty tier" with 40 percent coinsurance, leaves you with a $4,000 monthly out-of-pocket cost. That may be technically "covered" by your insurance plan, but it is not affordable for most patients.

The Inflation Reduction Act of 2022 established a $2,000 annual out-of-pocket maximum for Medicare Part D prescription drugs starting in 2025. For Medicare beneficiaries, this has meaningfully reduced the scope of the affordability problem. But for people with employer-sponsored insurance or individual marketplace plans, no equivalent cap exists, and out-of-pocket costs for specialty drugs can reach tens of thousands of dollars per year.

Ellen can help you find financial assistance options when your approved medication is still unaffordable. Start here →